Posted by ttee on May 3, 2007, at 17:31:50
In reply to Re: Emsam article on Wall Street Journal Online, posted by Shortstop on May 3, 2007, at 13:54:11
I don't know for sure how this would work, but I suppose that if BMS wanted to get out of the Emsam business, they (with Somerset) could sell the rights to some smaller company, like one of those drug orphan companies. At least they could get something by selling the rights and then maybe the smaller company could do a better job with the free PR sources, since Emsam will be on of their only products. It seems to me that anymore, if a drug is not blockbuster (billions), then the big drug companies don't want to bother with it.
poster:ttee
thread:755308
URL: http://www.dr-bob.org/babble/20070502/msgs/755571.html